Hak Eelko, Knol Lisanne M, Wilschut Jan C, Postma Maarten J
Rijksuniversiteit Groningen, Groningen Research Institute for Pharmacy (GRIP), unit Farmaco-epidemiologie & Farmaco-economie (FE2), Groningen, the Netherlands.
Ned Tijdschr Geneeskd. 2010;154:A1188.
To assess the annual productivity loss among hospital healthcare workers attributable to influenza and to estimate the costs and economic benefits of a vaccination programme from the perspective of the the employer.
Cost-benefit analysis.
The percentage of work loss due to influenza was determined using monthly age and gender specific figures for productivity loss among healthcare workers of the University Medical Center Groningen (UMCG), the Netherlands over the period January 2006-June 2008. Influenza periods were determined on the basis of national surveillance data. The average increase in productivity loss in these periods was estimated by comparison with the periods outside influenza seasons. The direct costs of productivity loss from the perspective of the employer were estimated using the friction cost method. In the sensitivity analyses various modelling parameters were varied, such as the vaccination coverage.
In the UMCG, with approximately 9,400 employees, the estimated annual costs associated with productivity loss due to influenza before the introduction of the yearly influenza vaccination program were € 675,242 or on average, € 72 per employee. The economic benefits of the current vaccination program with a vaccination coverage of 24% with a vaccine effectiveness of 71% were estimated at € 89,858 or € 10 per employee. The nett economic benefits of a vaccination program with a target vaccination coverage of 70% with a vaccine effectiveness of 71% were estimated at € 244,325 or € 26 per employee.
This modelling study performed from the perspective of the employer showed that an annual influenza vaccination programme for hospital personnel can save costs.
评估医院医护人员因流感导致的年度生产力损失,并从雇主角度估计疫苗接种计划的成本和经济效益。
成本效益分析。
利用荷兰格罗宁根大学医学中心(UMCG)2006年1月至2008年6月期间医护人员按年龄和性别划分的每月生产力损失具体数据,确定因流感导致的工作损失百分比。流感时期根据国家监测数据确定。通过与非流感季节的时期进行比较,估计这些时期生产力损失的平均增加情况。从雇主角度使用摩擦成本法估计生产力损失的直接成本。在敏感性分析中改变各种建模参数,如疫苗接种覆盖率。
在拥有约9400名员工的UMCG,在实施年度流感疫苗接种计划之前,估计每年因流感导致生产力损失的相关成本为675242欧元,平均每名员工72欧元。当前疫苗接种覆盖率为24%、疫苗效力为71%的疫苗接种计划的经济效益估计为89858欧元,即每名员工10欧元。目标疫苗接种覆盖率为70%、疫苗效力为71%的疫苗接种计划的净经济效益估计为244325欧元,即每名员工26欧元。
从雇主角度进行的这项建模研究表明,医院人员的年度流感疫苗接种计划可以节省成本。